These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9221935)

  • 1. GABA(A) and GABA(B) agonists and antagonists alter the phase-shifting effects of light when microinjected into the suprachiasmatic region.
    Gillespie CF; Mintz EM; Marvel CL; Huhman KL; Albers HE
    Brain Res; 1997 Jun; 759(2):181-9. PubMed ID: 9221935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic region.
    Gillespie CF; Huhman KL; Babagbemi TO; Albers HE
    J Biol Rhythms; 1996 Jun; 11(2):137-44. PubMed ID: 8744241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the phase shifting effects of gastrin releasing peptide when microinjected into the suprachiasmatic region.
    Albers HE; Gillespie CF; Babagbemi TO; Huhman KL
    Neurosci Lett; 1995 May; 191(1-2):63-6. PubMed ID: 7659293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic regulation of light-induced c-Fos immunoreactivity within the suprachiasmatic nucleus.
    Gillespie CF; Van Der Beek EM; Mintz EM; Mickley NC; Jasnow AM; Huhman KL; Albers HE
    J Comp Neurol; 1999 Sep; 411(4):683-92. PubMed ID: 10421877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA interacts with photic signaling in the suprachiasmatic nucleus to regulate circadian phase shifts.
    Mintz EM; Jasnow AM; Gillespie CF; Huhman KL; Albers HE
    Neuroscience; 2002; 109(4):773-8. PubMed ID: 11927159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y, GABA and circadian phase shifts to photic stimuli.
    Lall GS; Biello SM
    Neuroscience; 2003; 120(4):915-21. PubMed ID: 12927198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific effects of gastrin-releasing peptide in the suprachiasmatic nucleus.
    Kallingal GJ; Mintz EM
    Eur J Neurosci; 2014 Feb; 39(4):630-9. PubMed ID: 24528136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An NMDA antagonist inhibits light but not GRP-induced phase shifts when administered after the phase-shifting stimulus.
    Kallingal GJ; Mintz EM
    Brain Res; 2010 Sep; 1353():106-12. PubMed ID: 20682305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase shifts to light are altered by antagonists to neuropeptide receptors.
    Chan RK; Sterniczuk R; Enkhbold Y; Jeffers RT; Basu P; Duong B; Chow SL; Smith VM; Antle MC
    Neuroscience; 2016 Jul; 327():115-24. PubMed ID: 27090819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamatergic activity modulates the phase-shifting effects of gastrin-releasing peptide and light.
    Kallingal GJ; Mintz EM
    Eur J Neurosci; 2006 Nov; 24(10):2853-8. PubMed ID: 17156209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides phase shift the mammalian circadian pacemaker.
    Piggins HD; Antle MC; Rusak B
    J Neurosci; 1995 Aug; 15(8):5612-22. PubMed ID: 7643205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microinjection of NMDA into the SCN region mimics the phase shifting effect of light in hamsters.
    Mintz EM; Albers HE
    Brain Res; 1997 May; 758(1-2):245-9. PubMed ID: 9203556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAB receptor stimulation phase-shifts the mammalian circadian clock in vitro.
    Biggs KR; Prosser RA
    Brain Res; 1998 Oct; 807(1-2):250-4. PubMed ID: 9757057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin releasing peptide and neuropeptide Y exert opposing actions on circadian phase.
    Kallingal GJ; Mintz EM
    Neurosci Lett; 2007 Jul; 422(1):59-63. PubMed ID: 17597298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive allosteric modulators at GABAB receptors exert intrinsic actions and enhance the influence of baclofen on light-induced phase shifts of hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Pharmacol Biochem Behav; 2011 Oct; 99(4):712-7. PubMed ID: 21756929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of colocalized neuropeptides: functional significance in the circadian timing system.
    Albers HE; Liou SY; Stopa EG; Zoeller RT
    J Neurosci; 1991 Mar; 11(3):846-51. PubMed ID: 2002363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo.
    Mintz EM; Marvel CL; Gillespie CF; Price KM; Albers HE
    J Neurosci; 1999 Jun; 19(12):5124-30. PubMed ID: 10366645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrin-releasing peptide induces c-Fos in the hamster suprachiasmatic nucleus.
    Piggins HD; Goguen D; Rusak B
    Neurosci Lett; 2005 Aug; 384(3):205-10. PubMed ID: 15955628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA(B) receptor activation in the suprachiasmatic nucleus of diurnal and nocturnal rodents.
    Novak CM; Ehlen JC; Huhman KL; Albers HE
    Brain Res Bull; 2004 Jul; 63(6):531-5. PubMed ID: 15249119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of photic shifts with the 5-HT1A mixed agonist/antagonist NAN-190: intra-suprachiasmatic nucleus pathway.
    Sterniczuk R; Stepkowski A; Jones M; Antle MC
    Neuroscience; 2008 May; 153(3):571-80. PubMed ID: 18406538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.